Abraham Pedroza-Torres is a biomedical researcher with a strong interest in cancer biology, with particular emphasis on treatment resistance mechanisms in ovarian and breast cancer. His research focuses on the identification of molecular biomarkers—especially microRNAs and other non-coding RNAs—associated with chemoresistance, as well as the exploration of therapeutic targets through drug repositioning strategies. He has experience in genomic data analysis, differential expression profiling, and bioinformatic approaches applied to public cancer datasets. In parallel, his work seeks to bridge basic research with translational and educational perspectives, contributing to scientific dissemination and the communication of evidence-based information for patients and the broader community.